0001213900-23-041642.txt : 20230519
0001213900-23-041642.hdr.sgml : 20230519
20230519181549
ACCESSION NUMBER: 0001213900-23-041642
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSE ERIC A MD
CENTRAL INDEX KEY: 0001139301
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39421
FILM NUMBER: 23941872
MAIL ADDRESS:
STREET 1: 161 FORT WASHINGTON AVENUE
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc.
CENTRAL INDEX KEY: 0001814114
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
BUSINESS PHONE: 646-343-9298
MAIL ADDRESS:
STREET 1: 150 UNION SQUARE DRIVE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2
DATE OF NAME CHANGE: 20200603
4
1
ownership.xml
X0407
4
2023-05-17
0
0001814114
Orchestra BioMed Holdings, Inc.
OBIO
0001139301
ROSE ERIC A MD
C/O ORCHESTRA BIOMED HOLDINGS, INC.
150 UNION SQUARE DRIVE
NEW HOPE
PA
18938
1
0
0
0
0
Common Stock, par value $0.0001 per share ("Common Stock")
2023-05-17
4
M
0
2325
1.08
A
2325
D
Common Stock
2023-05-17
4
F
0
157
16.04
D
2168
D
Warrant (Right to Buy)
1.08
2023-05-17
4
M
0
2325
0
D
2023-01-26
2023-05-31
Common Stock
2325
0
D
On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock.
Represents the shares of Common Stock deemed withheld by the Issuer in connection with the cashless exercise.
Pursuant to Section 3(c) of the warrant, the price was calculated as the average closing price per share of Common Stock for the 20 trading days immediately preceding the date on which the notice of exercise was deemed to have been sent to the Issuer.
/s/ Matthew R. Schob, Attorney-in-Fact
2023-05-19